In 2022, The Kennedy Center Honors took an unexpected turn as the ceremony received an unanticipated dose of irreverent humor when Borat made a special appearance. Sacha Baron Cohen, in character as Kazakhstan’s best journalist, injected a comedic twist into the prestigious event by delivering a series of uproarious roasts paying tribute to U2.
South Korea’s Sole Vinyl Record Producer: A Behind-the-Scenes Look at the Unique Operation
In the heart of South Korea, the nation’s sole vinyl record producer operates as a beacon for analog enthusiasts in the digital age. This unique LP records manufacturing factory stands as a testament to the enduring appeal of vinyl in a world dominated by digital music. The mass production process within this facility involves a meticulous journey, starting with the creation of a master disc and progressing through the pressing, trimming, and packaging stages. Skilled technicians oversee the delicate art of vinyl mastering, ensuring the fidelity and authenticity of the sound. The pressing machines, reminiscent of a bygone era, work their magic, transforming raw vinyl pellets into the grooved discs that capture the warmth and nostalgia audiophiles crave. Each step in the process reflects a dedication to preserving the timeless charm of vinyl records, making this factory a vital hub for those who appreciate the tactile experience and sonic richness that only vinyl can deliver.
Lemmy Kilmister Rocks the Silver Screen With A Legendary Cameo in ‘Airheads’
Lemmy Kilmister, the iconic frontman of Motörhead, left a huge mark not only on the music scene but also on the silver screen with his legendary cameo in the film “Airheads.” As a symbol of rebellious rock ‘n’ roll spirit, Lemmy seamlessly integrated his raw energy and charisma into the film’s narrative in just 20 seconds.
Dave Grohl and Jack Black Team Up to Rock the Hanukkah Sessions with a Powerful Tribute to Rush’s ‘The Spirit of Radio’
In a spectacular celebration of musical talent and camaraderie, Dave Grohl and Greg Kurstin delivered a stunning homage to the legendary band Rush during the third installment of their “Hanukkah Sessions” in 2022. The renowned musicians, known for their collaborative holiday covers, took on Rush’s iconic “The Spirit of Radio” with all the finesse and flair as you’d expect. What made this performance even more extraordinary was the inclusion of the irrepressible Jack Black, whose charismatic presence added a new dimension to the tribute.
Fleetwood Mac’s Isolated Vocals For “The Chain”
“The Chain” by Fleetwood Mac was released on their critically acclaimed and commercially successful album “Rumours” in 1977. The album is one of the best-selling albums of all time and features some of Fleetwood Mac’s most iconic songs. “The Chain” is unique among the tracks on “Rumours” as it is the only song on the album credited to all five members of the band at the time: Lindsey Buckingham, Mick Fleetwood, Christine McVie, John McVie, and Stevie Nicks. The song was created by combining various unused studio takes, with each member contributing different parts to the final composition.
Rihanna’s Isolated Vocals For “Lift Me Up”
Rihanna’s “Lift Me Up” was released on October 28, 2022, by Westbury Road, Roc Nation, Def Jam, and Hollywood Records, as the lead single from the soundtrack album of the 2022 superhero film Black Panther: Wakanda Forever. The song marks Rihanna’s first solo music output since her 2016 studio album, Anti, and was written by Rihanna, Nigerian singer Tems, Ryan Coogler, and produced by Ludwig Göransson.
My Next Read: “Anatomy of 55 More Songs: The Oral History of 55 Hits That Changed Rock, R&B, and Soul” By Marc Myers
Following his 2016 smash hit Anatomy of a Song, acclaimed music journalist Marc Myers collects fifty-five new oral histories of iconic songs from his popular Wall Street Journal column.
Songs that sell the most copies become hits, but some of those hits become something more—iconic recordings that not only inspire a generation but also change the direction of music. In Anatomy of 55 More Songs, based on his column for the Wall Street Journal, music journalist and historian Marc Myers tells the story behind fifty-five rock, pop, R&B, country, and soul-gospel hits through intimate interviews with the artists who wrote and recorded them.
Part oral history, part musical analysis, Anatomy of 55 More Songs ranges from Creedence Clearwater Revival’s “Bad Moon Rising” to Dionne Warwick’s “Walk On By,” The Beach Boys’ “Good Vibrations,” and Black Sabbath’s “Paranoid.” Bernie Taupin recalls how he wrote the lyrics to Elton John’s “Rocket Man;” Joan Jett remembers channeling her rage against how she had been unfairly labeled and treated as a female rocker into “Bad Reputation;” and Ozzy Osbourne, Elvis Costello, Bob Weir, Sheryl Crow, Alice Cooper, Roberta Flack, John Mellencamp, Keith Richards, Carly Simon, and many others reveal the emotions and technique behind their major works.
This new, expanded edition of the book features three new songs: “Go Your Own Way” by Fleetwood Mac, “Why Can’t We Be Friends?” by War, and “Come On Eileen” by Dexys Midnight Runners. Through an absorbing chronological, song-by-song analysis of the most memorable post-war hits, Anatomy of 55 More Songs provides a sweeping look at the evolution of pop music between 1964 and today. This book will change how you listen to music and evaluate the artists who create it.
My Next Read: “The Listening Party Volume 2: Artists, Bands and Fans Reflect on Over 90 Favorite Albums” By Tim Burgess
Sit back, relax, and relive the memories of over 90 more classic albums selected by Tim Burgess from his legendary Listening Parties.
In less than 2 years, tens of thousands of music lovers have pressed play at the same time as legendary musicians to share the communal experience of a Listening Party. Over 1,000 online events, fans and artists – from McCartney to Blondie, Joy Division to Iron Maiden – have shared insightful recollections, intimate conversations and behind-the-scenes revelations. This follow-up to the bestselling The Listening Party Volume 1 gathers together over 90 more of the most essential parties and celebrates the unique power of a Listening Party to connect music creators with listeners. It’s an appropriate tribute to the unifying power of music and how it continues to enthrall millions around the world every single day.
Music Streaming Market Size to Grow USD 22610 Million by 2029 at a CAGR of 16.6%
Music Streaming Service Market Size is Segmented by Type (Software, Hardware), by Application (Personal, Commercial): Global Opportunity Analysis and Industry Forecast, 2023-2029. It is Published in Valuates Reports Under the Category of Online Media.
The Music Streaming Service market is projected to grow from USD 8984.2 million in 2023 to USD 22610 million by 2029, at a Compound Annual Growth Rate (CAGR) of 16.6% during the forecast period.
Throughout the course of the projected period, the increasing use of smart devices and the adoption of digital platforms are anticipated to propel market expansion. Because of the appealing features that these services offer like automatic playlist customization, personalized song recommendations, and seamless accessibility across multiple applications and web browsers their popularity which includes websites that let users view music videos and listen to podcasts in addition to audio files is significantly growing.
With music streaming services, consumers can access huge music libraries whenever they want, with never-before-seen convenience. The market’s expansion is mostly driven by this convenience aspect. No physical media or downloads are required because subscribers may instantly listen to their favorite songs, albums, and playlists. The market for music streaming has experienced tremendous growth due to the growing usage of smartphones and other mobile devices. Users can listen to music on the go with the help of mobile apps offered by streaming platforms, which has resulted in an increase in subscribers who value portability and flexibility in their music consumption.
A wide variety of users are drawn in by competitive pricing and free, ad-supported tiers. A wide range of people can access music streaming services thanks to their multiple subscription tiers, which include free, ad-supported options and premium, ad-free subscriptions.
A wide range of musical interests can be satisfied by the vast and varied music catalogs that music streaming services provide. They also provide users with tailored suggestions based on user data and algorithms, exposing them to new artists and music and increasing user engagement.
The rise of streaming services is being driven by a change in consumer behavior from music ownership to music access. Many consumers now prefer the subscription-based business model provided by streaming services over buying physical copies of music or single downloads.
North America has the greatest revenue share and is expected to expand significantly over the course of the forecast. The regional market is expanding due to the availability of online payment technologies, smart gadgets, and fixed wireless internet.
Between 2023 and 2030, the Middle East and Africa are projected to grow at the quickest rate among regional markets. The region’s growing internet penetration and growing smartphone usage trends have been key factors in the market’s expansion. Additionally, consumers now have a handy and portable way to access music streaming services thanks to cell phones. The market’s growth has been greatly aided by this tendency.
Hip-Hop Classic “It Takes Two” Takes on New Meaning in Remix to Elevate Importance of Testing for Kidney Disease
More than 35 million adults in the U.S. have chronic kidney disease (CKD). However, as many as 90% of them are unaware of their condition. This is despite clinical guidelines, which show that using two tests can help detect it. That’s why Boehringer Ingelheim and Eli Lilly and Company today announced the launch of It Takes 2 – a new health initiative to elevate the importance of complete testing and early diagnosis of kidney disease, particularly among those who have type 2 diabetes or high blood pressure and are at greater risk for it.
For It Takes 2, Boehringer Ingelheim and Lilly partnered with renowned musical artist Rob Base, who – alongside collaborator DJ E-Z Rock – famously declared that “it takes two to make a thing go right” in their 1988 mega-hit “It Takes Two.” More than three decades later, the sentiment still rings true, especially when it comes to managing kidney health. To mark the initiative’s launch, Rob Base has reimagined and rerecorded his classic single specifically for this cause. By turning “It Takes Two” into “It Takes 2 – The Remix,” he is helping Boehringer Ingelheim and Lilly reach key audiences to spotlight the significance of complete testing.
In addition to the new remix, the initiative addresses the critical need for complete CKD testing, with two tests, by providing tailored resources and educational content that underscore the importance of using both blood and urine tests, with dual messaging that speaks directly to healthcare professionals as well as adults at risk for CKD.
Clinical guidelines urge healthcare professionals to routinely screen for CKD using both the eGFR blood test and UACR urine test to decrease the risk of disease progression and serious, long-term complications. However, recent data reveals that less than 20% of adults with type 2 diabetes and high blood pressure – two of the main risk factors for developing kidney disease – received guideline concordant testing. It Takes 2 encourages healthcare professionals to add UACR testing to screen for CKD, as eGFR testing only tells half the story.
“Testing – and specifically early testing – is a significant gap in care that can have a detrimental impact on those at risk for CKD,” said Dr. Charles Vega, M.D., FAAFP, Associate Dean, Diversity and Inclusion, UC Irvine School of Medicine. “The stark reality is once symptoms develop, some degree of irreversible kidney damage may have already occurred. I am proud to support an initiative that is tackling this issue head-on by energizing healthcare professionals and patients to work together and follow guidelines from leading kidney and diabetes organizations. The unique approach of It Takes 2 in reaching two different audiences with two different, but equally valuable messages is a critical step forward in improving the treatment of adults in jeopardy of developing kidney disease.”
While diabetes and high blood pressure are responsible for up to two-thirds of kidney disease cases, people may not know that they have it. Many adults do not experience symptoms until their kidney disease has advanced. Kidney disease staging is based on kidney health and is used to guide treatment decisions. It Takes 2 empowers people to partner with their healthcare professional and test early and often to identify the stage as well as the risk of progression.
“It took nearly a decade to discover that I had kidney disease, and then I developed type 2 diabetes and high blood pressure, which now puts me at risk for heart failure, so I know how overwhelming it can be to understand and manage these interconnected conditions,” said Thelma Barber, an advocate living with CKD. “I also know that by remembering that It Takes 2 – me and my doctor – it is possible. I’m eager to lend my voice to It Takes 2 to inspire others with cardio-renal-metabolic conditions to talk to their doctor about complete testing and utilize the informative resources that this initiative provides. By tapping into a powerful combination of nostalgia and memorability, It Takes 2 is helping bring greater recognition to kidney disease.”
It Takes 2 – The Remix, which debuts in conjunction with hip-hop’s 50th anniversary celebration this year, reinforces the initiative’s objectives with rewritten lyrics that empower people to not only listen but take action. To bring the song to life, Rob Base and Boehringer Ingelheim and Lilly produced two shareable music videos for at-risk adults and healthcare professionals, which puts a modern spin on the beloved original to reflect It Takes 2 messaging. View the new videos and access educational resources on the It Takes 2 website at TestYourKidneys.com, as well as a version of the site for healthcare professionals at CKDtesting.com.
“‘It Takes Two’ is a defining piece of music history and the Boehringer Ingelheim and Lilly Alliance is excited to partner with Rob Base to reinvent this song to amplify the mission of our new health initiative,” said Mohamed Eid, M.D., M.P.H., M.H.A., vice president, Clinical Development & Medical Affairs, Cardio-Renal-Metabolism & Respiratory Medicine, Boehringer Ingelheim Pharmaceuticals, Inc. “It Takes 2 is driving attention to the value of using two complementary tests to help identify unmet needs of the at-risk population and reduce risks associated with the growing burden of CKD.”
“Our commitment to improve care for people with cardio-renal-metabolic conditions extends beyond treatments, to include bolstering awareness of the interconnected disorders,” said Leonard Glass, M.D., F.A.C.E., senior vice president, Diabetes Global Medical Affairs, Lilly. “More than one in seven U.S. adults are affected by CKD and a majority of them are undiagnosed. It Takes 2 recognizes this public health crisis and aims to prompt action among those who are at risk, as well as those who treat them, to help transform outcomes.”
It Takes 2 is a health initiative that aims to elevate the importance of testing and early diagnosis of chronic kidney disease (CKD) to help reduce the risk of serious complications down the road. The initiative provides tailored resources and educational content to empower adults at risk for kidney disease to work with their healthcare professional and request one simple urine test. It Takes 2 encourages healthcare professionals to proactively use two tests – eGFR blood test and UACR urine test – to get the full picture about CKD. Learn more about It Takes 2 and access helpful resources from the initiative’s website at TestYourKidneys.com, as well as a version of the site for healthcare professionals at CKDtesting.com.
Chronic kidney disease (CKD) is a progressive and potentially life-threatening condition that occurs when the kidneys are damaged by any cause that affects their ability to filter the blood. Kidney disease staging is based on kidney health and is used to guide treatment decisions. Most adults in the U.S. living with kidney disease are unaware of their condition – and many do not know that they are at risk until symptoms emerge when their disease becomes advanced and irreversible kidney damage has occurred.
CKD is part of a collective group of diseases known as cardio-renal-metabolic (C-R-M) conditions that are closely intertwined and share many of the same disease-related pathways and risk factors. Dysfunction in one area of the C-R-M system may accelerate the onset of dysfunction in others. As such, people with CKD are potentially living with other C-R-M conditions, such as heart failure and type 2 diabetes. The two main causes of kidney disease are diabetes and high blood pressure, which are responsible for up to two-thirds of CKD cases.
In January 2011, Boehringer Ingelheim and Eli Lilly and Company announced an Alliance that centers on compounds representing several of the largest diabetes treatment classes. Depending on geographies, the companies either co-promote or separately promote the respective molecules each contributing to the Alliance. The Alliance leverages the strengths of two of the world’s leading pharmaceutical companies to focus on patient needs. By joining forces, the companies demonstrate their commitment, not only to the care of people with diabetes, but also to investigating the potential to address areas of unmet medical need.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma and Animal Health. Learn more at boehringer-ingelheim.com/us/.
Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram, Twitter and LinkedIn.